Quaker Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Quaker Wealth Management's ABBV Position: Q2 2026 in Review
Quaker Wealth Management increased its AbbVie (ABBV) stake by 1.3% in Q2 2026, buying an estimated $2.58K and bringing the position to 969 shares worth $244K. The position accounts for 0.07% of the portfolio, ranked #62.
Quaker Wealth Management first reported a position in ABBV in Q3 2024 and has held it in 6 quarters since. 1,470 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Quaker Wealth Management held 969 shares of AbbVie worth $244K as of Q2 2026.
- Quaker Wealth Management bought 12 AbbVie shares in Q2 2026, an estimated $2.58K.
- AbbVie made up 0.07% of Quaker Wealth Management's portfolio in Q2 2026, its #62 holding.
- Quaker Wealth Management first reported a position in AbbVie in Q3 2024 and has held it in 6 quarters since.
- 1,470 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.